This content is machine translated Type 2 diabetes - update for the family doctor Aim for multifactorial rather than glucocentric treatment With regard to cardiac and renal protection, it is increasingly recommended to combine metformin initially with an SGLT-2 inhibitor or a GLP-1 receptor agonist. In contrast, sulfonylureas and DPP-4 inhibitors…
View Post 13 min This content is machine translated Type 2 diabetes Focus on heart & kidney: therapy choice in patients with limiting factors Classes of drugs with different mechanisms of action are available for the treatment of type 2 diabetes. However, the presence of renal or cardiac insufficiency, cardiovascular disease, or insulin deficiency…
View Post 8 min This content is machine translated Insulin in type 2 diabetes When and in which combination? The current therapy guidelines for diabetes mellitus type 2 provide for the use of insulin as initial therapy as well as a later therapy option in monotherapy or in combination with…
